ANGO vs OGN · rev $292.5M vs P/E 3.4, rev $6.40B
AngioDynamics Inc (ANGO) versus Organon & Co (OGN) — a side-by-side from cached financials, not a winner call.
AngioDynamics Inc (ANGO) is a medical instruments & supplies company listed on US.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Latest reported ANGO revenue for 2025-05-31 was $292.5M. Net income was -$34.0M. Revenue was down 3.8% from 2024-05-31 to 2025-05-31. ANGO currently screens at market cap $378.5M.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
ANGO currently screens at market cap $378.5M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Not investment advice. Open the ANGO and OGN stock pages for the full models.
Not investment advice.